NANedhal Abdulmawla Al-Selwi

Nedhal Abdulmawla Al-Selwi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nedhal Abdulmawla Al-Selwi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synthesis, Spectroscopic Characterization, and Antibacterial Evaluation of Novel Organophosphorus Schiff Base Derivatives Derived from Chlorodiphenylphosphine

    by Dheya A. Hameed, Fathi M. Al-Azab, Yasmin M.S. Jamil, Nedhal A.A. Al-Selwi, Gamil M.S. Qasem

    In this study, three novel organophosphorus Schiff base derivatives (OPC1–OPC3) were successfully synthesized by condensing chlorodiphenylphosphine with different Schiff bases derived from various aldehydes and hydrazine derivatives. The structural elucidation of the synthesized compounds was achieved using comprehensive spectroscopic analyses, including FTIR, UV-Vis, and both 1H and 13C NMR spectroscopy. Elemental analysis and physical property measurements further confirmed the proposed molecular structures. Spectroscopic data revealed characteristic azomethine (C=N), phosphorus–carbon (P–C), and phosphorus oxygen (P–O–C) stretching bands, confirming the successful formation of the organophosphorus Schiff base framework. The synthesized compounds were tested for antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus using the agar well diffusion method. The results demonstrated that all compounds exhibited moderate to significant antibacterial activity, with OPC2 and OPC3 showing notable inhibition zones compared to OPC1. These findings suggest that the incorporation of organophosphorus moieties into Schiff base ligands enhances their biological potency and provides a promising route for developing new bioactive organophosphorus materials.

  • Open Access

    From Synthesis to Bioactivity: A Ti(IV)-Coordinated Phosphorylated Schiff Base System with XRD-Validated Structure and Enhanced Efficacy Against Multidrug-Resistant Bacterial Pathogens

    by Dheya A. Hameed, Nedhal A. A. Al-Selwi, Fathi M. Al-Azab, Yasmin M.S. Jamil, Ahmed N Alhakimi, Gamil M.S. Qasem, Thamer Alorini, Abuzar E. A. Albadri

    A novel organophosphorus Schiff base ligand, diphenyl (2-((2-phenylhydrazineylidene)methyl)phenyl) phosphate (OPSBL), was synthesized through the reaction of 2-(2-phenylhydrazineylidene)methyl phenol with diphenylchlorophosphate. Its Ti(IV) complex, [Ti(OPSBL)Cl₂]Cl₂·2H₂O, was prepared in a 1:2 molar ratio (metal: ligand) and characterized via IR, UV-Vis, ¹H/¹³C NMR, XRD, and elemental analysis. The complex exhibited electrolytic behavior, as confirmed by molar conductance measurements (134.18 Ω⁻¹ cm² mol⁻¹). XRD analysis revealed reduced crystallinity (41%) and smaller particle size (~300 nm) compared to the ligand, attributed to structural disarray and disrupted intermolecular interactions upon metal coordination. Molecular docking studies against Staphylococcus aureus (4URM), Bacillus subtilis (2RHL), and Escherichia coli (4PRV) demonstrated strong binding affinities (−6.00 to −6.52 kcal/mol), particularly targeting resistance-associated enzymes. Antibacterial assays against multidrug-resistant pathogens showed superior inhibitory activity for the Ti(IV) complex vs. the free ligand (25 mm vs. 18 mm at 300 µg/mL against E. coli. These findings highlight the potential of Ti(IV)-Schiff base systems as a preliminary indication of multi-target potential against resistant bacterial infections, combining structural stability with bioactivity. Further studies on cytotoxicity and single-crystal validation are warranted.


  • Open Access

    Evaluation of the effectiveness of new mixed ligand complexes against the vector of Dengue fever Aedes aegypti (Diptera; Culicidae)

    by Nedhal Abdulmawla Al-Selwi, Abbas Mohamed Al-Azab, Yasmin Mosa’d Saeed Jamil, Fathi Mohamed Al-Azab, Anwar Mohamed Al-Ryami

    Chloroquine phosphate with ibuprofen and sulphamethoxazole were used as mixed ligands with Ni(II), Co(II), Cu(II), and Zn(II) to prepare new transition metal complexes. Metal analysis, IR, and X-ray diffraction (XRD) spectrum analyzes were used to describe them, with some modifications to the World Health Organization (WHO) standard susceptibility test under laboratory conditions. The biological effects of ligands and new complexes against Aedes aegypti mosquito larvae were evaluated at various concentrations. To assess larvicidal efficacy, late third or early fourth instar larvae were exposed to multiple concentrations of the examined compounds, ranging from 50 to 1000 ppm. Cu(II) complexes revealed significant high activity (LC50 = 100 ppm against Ae. Aegypti was compared with the rest of the metal complexes. On the other hand, the Co(II) complex showed no activity against Ae. aegypti. These mixed ligand complexes seemed to be an alternative method for manufactured insecticides to control larvae of this medically important mosquito vector Ae. aegypti. Further research on other metal complex compounds responsible for larvicidal efficacy will be required.


  • Open Access

    Novel organophosphorus Schiff base ligands: Synthesis, characterization, ligational aspects, XRD and biological activity studies

    by Yasmin Mos'Ad Jamil, Fathi Mohammed Al-Azab, Nedhal Abdulmawla Al-Selwi

    Six complexes have been synthesized from Cu(II), Ni(II), and Co(II) with new bidentate N2 donor Schiff base ligand (2-methoxybenzalidene-1-phenylsemicarbazide L1) and tridentate N2O donor organophosphorus Schiff base ligand (2-methoxybenzalidenediphenylphosphate-1-phenylsemicarbazide L2). Both ligands were synthesized and characterized by metal analysis, infrared (IR), ultraviolet visible (UV-Vis), and nuclear magnetic resonance (NMR) spectral studies. The chemical structures of the synthesized complexes were characterized using their metal analysis, magnetic susceptibility, molar conductance, IR, and UV-Vis spectra. According to molar ratio studies, the complexes have the composition of ML2 for L1 and ML for L2. The X-ray diffraction (XRD) studies showed that the particle size of ligands and L1 complexes were in nano-range. The ligands and their metal complexes have been screened for their antioxidant, antibacterial and antifungal activity.